These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4956039)

  • 21. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short- and long-term humoral immune response against Yersinia pestis in plague patients, Madagascar.
    Andrianaivoarimanana V; Iharisoa AL; Rahalison L; Ralimanantsoa ML; Ratsitorahina M; Rakotonanahary RJL; Carniel E; Demeure C; Rajerison M
    BMC Infect Dis; 2020 Nov; 20(1):822. PubMed ID: 33172393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agar-gel precipitin-inhibition technique for histoplasmosis antibody determinations.
    Ray JG
    Appl Microbiol; 1967 Jul; 15(4):794-9. PubMed ID: 4963441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pesticinogeny: a characteristic useful for presumptive identification and isolation of Pasteurella pestis.
    Beesley ED; Surgalla MJ
    Appl Microbiol; 1970 Jun; 19(6):915-8. PubMed ID: 4989537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agar-gel precipitin-inhibition test for coccidioidomycosis. I. Preliminary evaluation of the complement-fixation and agar-gel precipitin tests in the serodiagnosis of human coccidioidomycosis.
    Ray JG
    Appl Microbiol; 1967 Sep; 15(5):1049-53. PubMed ID: 4965616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of blood group substance A bound to Pasteurella pestis.
    Luzzio AJ
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):853-8. PubMed ID: 5791799
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunity in plague: protection of the vervet (Cercopithecus aethips) against pneumonic plague by the oral administration of live attenuated Yersinia pestis.
    Chen TH; Elberg SS; Eisler DM
    J Infect Dis; 1977 Feb; 135(2):289-93. PubMed ID: 402428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dynamics of F1 antibody responses to
    Meng WW; ; Wang XH; ; ; Luo T; Li B; ; Wang QG; Guo R; Dai X; Zhang YJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):353-357. PubMed ID: 28395471
    [No Abstract]   [Full Text] [Related]  

  • 29. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization.
    Hill J; Leary SE; Griffin KF; Williamson ED; Titball RW
    Infect Immun; 1997 Nov; 65(11):4476-82. PubMed ID: 9353022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis.
    Meyer KF; Hightower JA; McCrumb FR
    J Infect Dis; 1974 May; 129():Suppl:S41-5. PubMed ID: 4825248
    [No Abstract]   [Full Text] [Related]  

  • 31. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.
    Simpson WJ; Thomas RE; Schwan TG
    Am J Trop Med Hyg; 1990 Oct; 43(4):389-96. PubMed ID: 2240367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
    Zauberman A; Gur D; Levy Y; Aftalion M; Vagima Y; Tidhar A; Chitlaru T; Mamroud E
    J Infect Dis; 2019 Aug; 220(7):1147-1151. PubMed ID: 31095689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLAGUE.
    BURKE-GAFFNEY HJ
    Trop Dis Bull; 1964 Jul; 61():633-9. PubMed ID: 14153184
    [No Abstract]   [Full Text] [Related]  

  • 34. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological response of rhesus monkeys (Macaca mulatta) to immunization and infection with Pasteurella pestis.
    Marshall JD; Harrison DN; Rust JH; Cavanaugh DC
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):738-41. PubMed ID: 5000786
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plague and its agents (current state of our knowledge)].
    Knapp W
    Cah Med; 1970 Jul; 11(9):779-86. PubMed ID: 4989215
    [No Abstract]   [Full Text] [Related]  

  • 38. [Problems of immunogenesis in vaccination with live bacterial vaccines. I].
    Saltykov RA; Chalisov IA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):54-8. PubMed ID: 4217512
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative tests for detection of plague antigen and antibody in experimentally infected wild rodents.
    Shepherd AJ; Hummitzsch DE; Leman PA; Swanepoel R; Searle LA
    J Clin Microbiol; 1986 Dec; 24(6):1075-8. PubMed ID: 3097065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an up-converting phosphor technology-based 10-channel lateral flow assay for profiling antibodies against Yersinia pestis.
    Hong W; Huang L; Wang H; Qu J; Guo Z; Xie C; Zhu Z; Zhang Y; Du Z; Yan Y; Zheng Y; Huang H; Yang R; Zhou L
    J Microbiol Methods; 2010 Nov; 83(2):133-40. PubMed ID: 20801166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.